Response to: Asymptomatic neurocognitive impairment is a risk for symptomatic decline over a 3-year study period.

Journal: AIDS (London, England)

Publication Year: 2021

Authors & Co-authors:  Nightingale Sam S Dreyer Anna J AJ Gisslén Magnus M Winston Alan A Joska John A JA

Blood and cerebrospinal fluid biomarker changes in patients with HIV-associated neurocognitive impairment treated with lithium: analysis from a randomised placebo-controlled trial.

Journal: Journal of neurovirology

Publication Year: 2023

Authors & Co-authors:  Thela Lindokuhle L Decloedt Eric E Zetterberg Henrik H Gisslén Magnus M Lesosky Maia M Gleich Melanie M Koutsilieri Eleni E Scheller Carsten C Hye Abdul A Joska John J

Moving on From HAND: Why We Need New Criteria for Cognitive Impairment in Persons Living With Human Immunodeficiency Virus and a Proposed Way Forward.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Publication Year: 2021

Authors & Co-authors:  Nightingale Sam S Dreyer Anna J AJ Saylor Deanna D Gisslén Magnus M Winston Alan A Joska John A JA